Results 161 to 170 of about 28,778 (289)

Colistin Resistance in Enterobacterales

open access: yesRevista de salud publica del Paraguay, 2022
openaire   +1 more source

Chloramphenicol activity against carbapenemase producing Enterobacterales

open access: yesJournal of Global Antimicrobial Resistance
xx
Camarlinghi, Giulio   +6 more
openaire   +3 more sources

Analysis of Susceptibilities of Carbapenem Resistant Enterobacterales to Colistin in Intra-Abdominal, Respiratory and Urinary Tract Infections from 2015 to 2017

open access: yesInfection and Drug Resistance, 2020
Hui Zhang,1 Jingjia Zhang,1 Yue Kang,2 Qiwen Yang,1 Yingchun Xu1 1Division of Microbiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, People’s Republic of China; 2MRL Global ...
Zhang H, Zhang J, Kang Y, Yang Q, Xu Y
doaj  

Activity and resistance mechanisms of the third generation tetracyclines tigecycline, eravacycline and omadacycline against nationwide Spanish collections of carbapenemase-producing Enterobacterales and Acinetobacter baumannii.

open access: yesBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
INTRODUCTION The rise in multidrug-resistant bacteria challenges clinical microbiology. Tigecycline, eravacycline, and omadacycline show promise against carbapenem-resistant Enterobacterales and Acinetobacter baumannii.
Patricia García   +15 more
semanticscholar   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Prevalence, genetic diversity of and factors associated with ESBL-producing Enterobacterales carriage in residents of French nursing homes

open access: yes, 2019
International audienceTo determine the prevalence and genotypic characteristics of extended-spectrum β-lactamase-producing Enterobacterales (ESBLE) and carbapenemase-producing Enterobacterales (CPE) in nursing homes (NHs) in a French region. Risk factors
Broussier, M.   +4 more
core   +1 more source

Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective, Single Center Study

open access: yesInfection and Drug Resistance
Chen-Huan Yu,1 Mao-Song Tsai,2 Chun-Hsing Liao,2 Chia-Jui Yang2 1Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan; 2Division of Infectious Disease, Department of Internal Medicine, Far Eastern Memorial Hospital, New
Yu CH, Tsai MS, Liao CH, Yang CJ
doaj  

Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients

open access: yesAntibiotics
We evaluated the activities of aztreonam/avibactam and recently approved β-lactamase inhibitor combinations (BLICs) to compare the antimicrobial susceptibility patterns of Enterobacterales and Pseudomonas aeruginosa isolated from intensive care unit (ICU)
H. Sader   +4 more
semanticscholar   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Efficacy assessment of different cryoprotectants for preserving the viability of Enterobacterales strains at − 20 °C

open access: yesScientific Reports
The preservation of microorganisms is pivotal in microbiological practice. Currently, cryopreservation is assumed to be an effective and inexpensive approach for the storage of microorganisms, including bacteria.
A. Tutrina, P. Zhurilov
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy